Directory of Research and Development Resources

Home > Business > Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development

Sites for companies specializing in research focusing on the treatment or curing cancer, using drugs, cellular and subcellular materials.

Resources in This Category

• ARIAD Pharmaceuticals, Inc.

  http://www.ariad.com/
  Develops drugs which block intracellular signal transduction pathways for treating solid tumors and hematologic malignancies. Includes kits available, technology overview and investor data from Cambridge, Massachusetts. (Nasdaq: ARIA)

• Arqule, Inc.

  http://www.arqule.com/
  Promotes their activated checkpoint therapy platform. Headquartered in Woburn, Massachusetts. (Nasdaq: ARQL)

• Dendreon Corp.

  http://www.dendreon.com/
  Discovers and develops immunologically based therapeutic anticancer products. Includes progress of clinical trials, and data for investors from company based in Seattle, Washington. (Nasdaq: DNDN)

• Draxis Health Inc.

  http://www.draximage.com/
  Produces radiolabeled compounds for diagnostic and therapeutic use in nuclear medicine and oncology. Includes examples that distinguish infection from inflammation, a peptide based on fibrin, and overview of facilities in Kirkland, Québec. [English, French and Spanish]

• Exelixis, Inc.

  http://www.exelixis.com/
  Genomics-based discovery company focused on development of drugs, crop protection, and plant biotechnology. Overview of research, investor relations and contacts in California and Portland, Oregon. (Nasdaq: EXEL)

• Genaera Corp.

  http://www.genaera.com/
  Develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. Includes overview of clinical trials, investor information and news from company in Plymouth Meeting, Pennsylvania. (Nasdaq: GENR)

• Heal Corporation

  http://www.healcorp.net/
  Details of projects using resistance related to polyunsaturated fatty acids and catalase in vitro, applied in vivo to trout model. Includes publications, charity status, facilities and contacts in Olympia, Washington.

• ImmunoGen, Inc.

  http://www.immunogen.com/
  Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)

Related Categories

• Home > Business > Biotechnology and Pharmaceuticals > Pharmaceuticals > Research and Development

 

Home > Business > Biotechnology and Pharmaceuticals > Pharmaceuticals > Cancer > Research and Development

 

---

 

Thanks to DMOZ, which built a great web directory for nearly two decades and freely shared it with the web. About us